Health Condition 1: F20- Schizophrenia
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: Illness duration of =12 months and an overall moderate severity of the illness based on the Clinical Global Impression- Schizophrenia (CGI-SCH) scale. Eligible patients must also have at least one risk factor for early mortality which commonly occurs among individuals with schizophrenia such as hypertension, diabetes, dyslipidemia, current tobacco use, and/or overweight or obesity.
Exclusion criteria
Exclusion criteria: Participants who are planning to move out of the study catchment areas in the next 12 months, and those who do not speak either of the primary local languages, Hindi in Madhya Pradesh or Kannada in Karnataka, individuals with a diagnosis of dementia, or evidence of significant cognitive impairment, individuals who have major visual impairment or who cannot operate a smartphone will be excluded.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Patient-Level Outcome Measures: 1. Disability Implementation-Level Outcome Measures: 1. Patient engagement in COPSITimepoint: Baseline, 6 and 12 months | — |
Secondary
| Measure | Time frame |
|---|---|
| Implementation-Level Outcome Measures: 1. Fidelity of COPSI delivery 2. Costs of COPSI and mindLAMP vs. COPSI Timepoint: Baseline, 6 and 12 months;Patient-Level Outcome Measures: 1. Mental health: Symptoms, cognition. 2. Physical health and functional: sleep, QoL, social functioning, cardiovascular risk, health metrics. 3. Digital dataTimepoint: Baseline, 6 and 12 months | — |
Countries
India
Contacts
National Institute of Mental Health and Neuroscience